. Author manuscript; available in PMC: 2020 Jan 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Oct 17;28(1):76–82. doi: 10.1158/1055-9965.EPI-18-0654

Table 2.

Summary of adiposity and inflammation- and angiogenesis-related biomarker measurements (geometric mean ± SD) among 188 colorectal cancer patients.

Adiposity (mean ± SD)
Subcutaneous fat area, L3/L4 (cm²)	203 ± 89.5
Subcutaneous fat area, L4/L5 (cm²)	237 ± 93.3
Visceral fat area, L3/L4 (cm²)	173 ± 100
Visceral fat area, L4/L5 (cm²)	148 ± 78.9
Ratio 1: VFA:SFA at L3/L4	0.91 ± 0.54
Ratio 2: VFA:SFA at L4/L5	0.66 ± 0.35
Inflammation and angiogenesis-related biomarkers (mean ± SD)
VEGF-A (pg/L)	827 ± 583
VEGF-D (pg/L)	859 ± 304
CRP (mg/L)	12.0 ± 20.6
SAA (mg/L)	18.4 ± 34.7
sICAM-1 (mg/L)	0.50 ± 0.22
sVCAM-1 (mg/L)	066 ± 0.34

Abbreviations: SD, standard deviation; cm, centimeters; VFA: visceral fat area; SFA: subcutaneous fat area; mg: milligrams; L: liters; VEGF-A: vascular endothelial growth factor A; VEGF-D: vascular endothelial growth factor D; CRP: C reactive protein; SAA: serum amyloid A; sICAM-1: soluble intracellular cell adhesion molecule 1; sVCAM-1: soluble vascular cell adhesion molecule 1.